CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $347,711,405
- in 75 filings, $346.9M under 10b5-1 plans
Net −$347,711,405. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-05 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $117.76 | $1.1M | 333,943 |
| 2026-10-05 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −501 | $536.26 | $269K | 333,442 |
| 2026-10-05 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −905 | $537.43 | $486K | 332,537 |
| 2026-10-05 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −655 | $538.62 | $353K | 331,882 |
| 2026-10-05 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −931 | $539.50 | $502K | 330,951 |
| 2026-10-05 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,028 | $540.50 | $556K | 329,923 |
| 2026-10-05 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,239 | $541.66 | $671K | 328,684 |
| 2026-10-05 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −918 | $542.56 | $498K | 327,766 |
| 2026-10-05 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −783 | $543.54 | $426K | 326,983 |
| 2026-10-05 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,260 | $544.59 | $686K | 325,723 |
| 2026-10-05 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −920 | $545.69 | $502K | 324,803 |
| 2026-10-05 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −360 | $546.63 | $197K | 324,443 |
| 2026-10-05 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 299,910 | ||
| 2026-10-02 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $117.76 | $1.1M | 333,943 |
| 2026-10-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −700 | $542.06 | $379K | 333,243 |
| 2026-10-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −408 | $542.87 | $221K | 332,835 |
| 2026-10-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,032 | $544.17 | $562K | 331,803 |
| 2026-10-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,280 | $544.90 | $697K | 330,523 |
| 2026-10-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −309 | $546.75 | $169K | 330,214 |
| 2026-10-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,171 | $547.99 | $642K | 329,043 |
Page 25 of 121 · 2,404 trades